Discover 3,507 paid clinical trials in Santa Monica, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,507
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
for
Nausea and Vomiting, Obesity
Location: Los Angeles CA, San Diego CA, Tampa FL
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT07446439
Phase 3, Recruiting
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
for
Solid Tumors
Location: Los Angeles CA, Portland OR, Wheat Ridge CO,
Sponsor: DualityBio Inc.
Sex: All
Age: 18+
Code: NCT06953089
Phase 2, Recruiting
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
for
Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
Location: Los Angeles CA, Stanford CA, San Francisco CA,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT06767683
Phase 2, Phase 3, Recruiting
The Happiest Baby, Inc. SNOO Postmarket Surveillance Study
for
Infant Death, Serious Injury
Location: Los Angeles CA
Sponsor: Happiest Baby, Inc.
Sex: All
Age: 18+
Code: NCT06361303
Recruiting
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
for
Atopic Dermatitis
Location: Los Angeles CA, Northridge CA, Huntington Beach CA,
Sponsor: Pfizer
Sex: All
Age: 12+
Code: NCT07783425
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
for
Atopic Dermatitis
Location: Los Angeles CA, Fountain Valley CA, Fremont CA,
Sponsor: Oneness Biotech Co., Ltd.
Sex: All
Age: 18 - 65
Code: NCT06397911
Phase 2, Recruiting
SCAN Memory Program Evaluation Study
for
Dementia
Location: Los Angeles CA, Calabasas CA
Sponsor: VA Greater Los Angeles Healthcare System
Sex: All
Age: 18+
Code: NCT01182987
Recruiting
18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer